Patient Care
We deliver high-quality care with innovation and empathy.
We deliver high-quality care with innovation and empathy.
PRACTICE SUPPORT
Products
Thousands of end stage renal disease experts turn to Renal Therapies Group for pharmaceuticals and the most prescribed technologies in the industry.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Insights
Our Company
More
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
Chief Development Officer
Tony Lafata joined National Cardiovascular Partners in January 2017, bringing with him years of experience in the corporate development sector.
As chief development officer, Tony is responsible for facilitating strategic partnerships with cardiac catheterization labs across the country. He brings more than thirty years of healthcare industry experience to the NCP executive team, with more than ten years in corporate development with Fresenius Medical Care, where he currently serves as the senior vice president of corporate development.
Tony currently lives in Kansas City, Missouri.
© 2006-2023 Fresenius Medical Care. All Rights Reserved.